LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 15.58 | 27.76 | 1034 | 685 | 1.5082 | 1.1858 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 17.28 | 27.76 | 2 | 838 | 0.0024 | -0.4143 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 17.28 | 27.76 | 257 | 838 | 0.3064 | 0.5724 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 17.28 | 27.76 | 10 | 838 | 0.0119 | -0.1875 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 17.28 | 27.76 | 1130 | 838 | 1.3473 | 1.1250 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 18.98 | 27.76 | 5 | 941 | 0.0053 | -0.2862 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 18.98 | 27.76 | 326 | 941 | 0.3464 | 0.6235 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 18.98 | 27.76 | 14 | 941 | 0.0149 | -0.1260 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 18.98 | 27.76 | 1194 | 941 | 1.2687 | 1.0959 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 20.68 | 27.76 | 5 | 1119 | 0.0045 | -0.2749 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 20.68 | 27.76 | 364 | 1119 | 0.3253 | 0.6202 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 20.68 | 27.76 | 33 | 1119 | 0.0295 | 0.0330 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 20.68 | 27.76 | 1309 | 1119 | 1.1698 | 1.0597 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 22.39 | 27.76 | 3 | 1305 | 0.0023 | -0.3300 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 22.39 | 27.76 | 440 | 1305 | 0.3370 | 0.6444 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 22.39 | 27.76 | 41 | 1305 | 0.0314 | 0.0727 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 22.39 | 27.76 | 1404 | 1305 | 1.0753 | 1.0263 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 24.09 | 27.76 | 5 | 1461 | 0.0034 | -0.2590 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 24.09 | 27.76 | 502 | 1461 | 0.3435 | 0.6591 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 24.09 | 27.76 | 35 | 1461 | 0.0239 | 0.0414 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 24.09 | 27.76 | 1483 | 1461 | 1.0146 | 1.0051 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 25.79 | 27.76 | 1 | 1605 | 0.0006 | -0.4332 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 25.79 | 27.76 | 546 | 1605 | 0.3402 | 0.6635 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 25.79 | 27.76 | 36 | 1605 | 0.0224 | 0.0454 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 25.79 | 27.76 | 1603 | 1605 | 0.9987 | 0.9995 | MN20160318_Q01 | G16 |